ArticleJournal of cataract and refractive surgery2026
Study on the relationship between bacterial endotoxin and the onset of toxic anterior segment syndrome.
Article in Journal of cataract and refractive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo comprehensively analyze the contamination status of pyrogen including bacterial endotoxins, considered as one of the onset agents of toxic anterior segment syndrome (TASS), in medical devices used for cataract surgery, and to improve the cleanliness of the devices by new sterilization technology.
settingInnovative Decontamination Technology Development and Evaluation Center, Miura Co. Ltd., Yokohama, Japan.
designExperimental study.
methodsThe pyrogen levels of the medical devices were evaluated using a direct human cell-based pyrogen test that is not affected by the recovery ratio, unlike the endotoxin test. Pyrogen inactivation tests were further performed using low-temperature ozone/hydrogen peroxide mixed gas sterilization.
resultsSignificant pyrogen levels from 0.22 to 11.6 endotoxin units (EU)/product as a worst case were detected in 7 of 11 medical devices. These products might have exceeded the previously reported threshold (0.02 to 0.05 EU/eye) for inducing dose-dependent inflammatory responses in the mammalian vitreous during actual use. However, our study revealed that pyrogen contamination in the devices was reduced below the detection limit after ozone/hydrogen peroxide mixed gas sterilization under an elaborate treatment mode at 50°C.
conclusionsThe precise amount of pyrogen required to induce human TASS remains unknown; however, currently available medical products for intraocular surgery were found to be contaminated with nonnegligible amounts of pyrogens, and the possibility of a causal relationship between actual product use and the onset of TASS cannot be ruled out. This potential risk could be eliminated by replacing the current sterilization method with ozone/hydrogen peroxide mixed gas treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.